Advocates Say Mental Health Parity Remains A Challenge A Decade After Landmark Law Passed

Modern Healthcare (10/5, Johnson, Subscription Publication) reported that a decade after the “landmark” Mental Health Parity and Addiction Equity Act was passed, some “advocates contend access to care for millions remains elusive.” Modern Healthcare said the problems stem from “a lack of consistency in the oversight and enforcement on the part of federal and state regulators to get insurers to comply with existing parity laws.” A report this week from ParityTrack found that 43 states had low marks in mental health parity.

Related Links:

— “Mental health parity remains a challenge 10 years after landmark law, “Steven Ross Johnson, Modern Healthcare, October 5, 2018.

First-Time Mothers In Their Third Trimester Of Pregnancy During The Seasons With Shorter Daylight Hours May Be At Greater Risk For Postpartum Depression, Small Study Suggests

Healio (10/8) reports, “First-time mothers in their third trimester of pregnancy during the seasons with shorter daylight hours were at greater risk for postpartum depression,” researchers concluded. The findings of the 279-woman study were published online Sept. 27 in the Journal of Behavioral Medicine.

Related Links:

— “Fewer daylight hours in late pregnancy linked to depression, Healio, October 8, 2018.

Sexual Minority Adolescents May Be More Likely Than Their Peers To Attempt Suicide, Meta-Analysis Suggests

Reuters (10/8, Carroll) reports, “LGBT adolescents are more likely than other kids their age to try to kill themselves,” research indicated. In fact, “data pooled from 35 earlier studies show that sexual minority youth were more than three times as likely to attempt suicide as heterosexual peers,” the meta-analysis found, with “transsexual youth” being “at highest risk, nearly six times as likely to attempt suicide as heterosexual peers.” The findings were published online Oct. 8 in JAMA Pediatrics. MedPage Today (10/8, Hlavinka) also covers the study.

Related Links:

— “LGBT youth at higher risk for suicide attempts, “Linda Carroll, Reuters, October 8, 2018.

Medicare Commission Sees Need For Improved Opioid Tracking In Hospitals

Congressional Quarterly (10/4, Williams, Subscription Publication) reports “opioid use among Medicare patients has fallen by 18 percent in recent years but remains widespread.” Medicare Payment Advisory Commission (MedPAC) experts reviewed data “showing nearly one in three enrollees in the government health program filled at least one opioid prescription in 2016.” Rachel Schmidt, a principal policy analyst for MedPAC, said, “Even though it’s cut back some, it’s still a lot of people.” The commission sees a need for better opioid tracking at hospitals and is expected to final recommendations due to Congress in March.

Related Links:

— “Congressional Quarterly, Subscription Publication, October 4, 2018.

Study Suggests Integrating Mental Health Professionals In Cancer Care Team

Oncology Nurse Advisor (10/2, Garbutt) reports on a study presented at 2018 ASCO Quality Care Symposium in Phoenix, Arizona, finding that integrating “mental health professionals into the cancer care team can improve recognition and management of delirium in cancer patients.” For the study at the Cleveland Clinic, “psychiatrists, psychologists, and clinical social workers accompanied caregivers on multidisciplinary rounds to facilitate discussions about delirium and its management.” The findings appear in the Journal of Clinical Oncology.

Related Links:

— “Integrating Mental Health Into Multidisciplinary Oncology Care Improves Inpatient Care, “Tiffany Garbutt, PhD, Oncology Nurse Advisor, October 02, 2018.

Op-Ed: Talking About Suicide Can Help With Prevention, Reduce Stigma

Marc Siegel MD, professor of medicine and medical director of Doctor Radio at NYU Langone Health writes in an op-ed for The Hill (10/1) to discuss the rising suicide rates in the US, saying “the numbers are not subtle.” A report by the CDC found that “between 1999 and 2016 suicide rates increased in almost all states, with a greater than 30 percent increase in 25 states.” CDC’s Director of the National Center for Injury Prevention and Control Dev Houry says research “demonstrates that many factors contribute to suicide beyond mental health conditions alone,” adding that “overdose misuse associated with the opioid overdose epidemic could be driving the suicide rate higher.” Siegel adds that “research has shown that talking about suicide not only doesn’t cause it to occur, but can also help prevent it, by breaking through an individual’s isolation and decreasing associated stigma.”

Related Links:

— “Suicide rates are rising across the US and the numbers are not subtle, “Dr. Marc Siegel, The Hill, October 01, 2018.

For Middle School Kids, Witnessing School Violence May Be As Bad As Being Bullied, Study Suggests

HealthDay (9/28, Dallas) reported, “For middle school students, witnessing school violence can be as bad as being bullied,” researchers concluded in a study that “involved nearly 4,000 students in Quebec.” The study revealed that children “who had seen physical assaults or someone carrying weapons in the eighth grade had a higher risk of drug use and delinquency later on.” The findings were published online Sept. 5 in the Journal of Epidemiology and Community Health.

Related Links:

— “Just Witnessing School Violence Can Leave Psychic Scars, “Mary Elizabeth Dallas, HealthDay, September 28, 2018.

Evidence Does Not Support Commercial Rush Of DNA Tests Designed To Inform Decisions Regarding Patients’ Psychiatric Medications, Review Indicates

STAT (9/28, Robbins) reported that “several dozen companies” are now “probing patients’ DNA in search of insights to help inform decisions about what psychiatry medications patients should take,” and are even “touting applications for depression, bipolar disorder, attention deficit hyperactivity disorder, and post-traumatic stress disorder.” Now, “some top psychiatrists say the evidence doesn’t support the commercial rush.” In fact, in a review published online April 25 in the American Journal of Psychiatry, “a task force of the American Psychiatric Association’s research council concluded that such genetic testing is not ready for prime time in their field.” The members of the task force wrote, “Although some of the preliminary published data sound promising…there is insufficient evidence to support widespread use of combinatorial pharmacogenetic decision support tools at this point in time.”

Related Links:

— “In the race to use genetic tests to predict whether antidepressants will work, science might be getting left behind, “Rebecca Robbins, STAT, September 28, 2018.

Employees’ Mental Health Costs Rising Twice As Fast As Other Medical Expenses, Data Indicate

CNBC (9/27, LaVito) reports data from Aetna Behavioral Health show that the amount spent by employers on mental health “has been rising at a rapid clip – with annual costs increasing twice as fast as all other medical expenses in recent years.” Darcy Gruttadaro, director of the American Psychiatric Association Foundation’s Center for Workplace Mental Health, said, “We all have a point at which stress can creep into negatively impacting our overall health and wellness,” and “employers are increasingly recognizing … the importance of taking care of health, well-being and mental health, and also the role stress, isolation, loneliness and some of these other factors can play in overall mental health and well-being.”

Related Links:

— “Anxiety is expensive: Employee mental health costs rise twice as fast as all other medical expenses, “Angelica LaVito, CNBC, September 27, 2018.